| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $66.3M | +27.5% |
| SG&A Expense | $17.0M | -8.8% |
| Pre-tax Income | -$45.6M | -27.5% |
| Income Tax | $35K | -91.9% |
| Net Income | -$45.6M | -26.1% |
| EPS (Basic) | -$0.52 | +30.7% |
| EPS (Diluted) | -$0.52 | +30.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $22.8M | +11.0% |
| Short-term Investments | $110.5M | -7.6% |
| Current Assets | $135.7M | -5.6% |
| Total Assets | $169.0M | -4.7% |
| Current Liabilities | $18.3M | +58.5% |
| Total Liabilities | $32.2M | -45.6% |
| Stockholders' Equity | $81.1M | -31.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$62.3M | -31.9% |
| Investing Cash Flow | $10.8M | +115.3% |
| Financing Cash Flow | $53.8M | -59.7% |